Conmed Names John Gallagher as CFO

Conmed Corporation has appointed John E. Gallagher as its new chief financial officer (CFO), effective July 15. Gallagher succeeds Todd Garner, who will remain with the company in an advisory capacity through November 2, 2026.

Gallagher was most recently CFO of pharmaceutical technology and services company Certara, beginning in 2023. Before that he was CFO of Cue Health from 2021 to 2023.

He previously worked for BD (Becton, Dickinson and Company), where he served in multiple positions over a nine-year tenure. When he joined BD in 2012, Gallagher was named corporate treasurer, a position he held throughout his stint at the company. He was also responsible for corporate finance, including leading FP&A, and was controller/chief accounting officers during two large acquisitions.

In 2018, he was promoted to senior VP and CFO of BD’s Medical Segment, its largest business segment. Before BD, he working in various finance leadership roles at General Electic Company and Ford Motor Company.

“We are pleased to welcome a talented and experienced financial executive of John’s caliber to CONMED,” said Patrick J. Beyer, Conmed’s president and CEO. “John brings deep healthcare and medical technology experience, an extensive history of public company leadership, and a proven track record of leading global finance organizations and supporting complex strategic initiatives. His combination of industry expertise, financial leadership, and operational partnership experience make him exceptionally well-positioned to help CONMED execute its strategic priorities. I am excited to work alongside John as we focus on our strategic priorities, delivering strong execution, and creating long-term value for our shareholders.”

“I am excited to join CONMED and look forward to working closely with Pat and the rest of the CONMED team to further enhance the company’s operating and financial performance,” added Gallagher. “CONMED has built a differentiated portfolio in high-growth surgical categories, and I look forward to partnering with Pat and the team to drive the next chapter of value creation for our shareholders.”